ArticleSarcoma2018
Comparison of Epidemiology, Clinical Features, and Outcomes of Patients with Reported Ewing Sarcoma and PNET over 40 Years Justifies Current WHO Classification and Treatment Approaches.
Article in Sarcoma, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Leveraging Large Language Models to Extract Prognostic Pathology Features in Ewing Sarcoma.bioRxiv : the preprint server for biology · 2026Article
- Case report and review of the literature regarding management of primary uterine primitive neuroectodermal tumors (PNET).Gynecologic oncology reports · 2025Article
- Pediatric thoracic spinal Ewing sarcoma/primitive neuroectodermal tumor: a case report and literature review.Frontiers in pediatrics · 2025Article
- Risk-Stratified Radiotherapy in Pediatric Cancer.Cancers · 2024Review
- Diagnosis and management of cancer therapy-related myocarditis in a young female: A case report and review of literature.BMC cardiovascular disorders · 2024Review
- In vivo 3D profiling of site-specific human cancer cell morphotypes in zebrafish.The Journal of cell biology · 2022Article
- Soft-tissue Sarcoma Survival in the US Military Health System: Comparison With the SEER Program.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2022Article
- A novel nomogram and risk classification system predicting the Ewing sarcoma: a population-based study.Scientific reports · 2022Article
- Inhibitors of EYA3 Protein in Ewing Sarcoma.Asian Pacific journal of cancer prevention : APJCP · 2022Article
- Comparative international incidence of Ewing sarcoma 1988 to 2012.International journal of cancer · 2021Article
- Ewing sarcoma outcomes in a country with limited resources: Egypt as an example.American journal of cancer research · 2021Article
- Primitive neuroectodermal tumors of the abdominal wall and vulva in children: Report of two cases and review of the literature.World journal of clinical cases · 2019Article
- A nomogram for determining the disease-specific survival in Ewing sarcoma: a population study.BMC cancer · 2019Article
- Ewing's sarcoma/peripheral primitive neuroectodermal tumor with extraskeletal myxoid chondrosarcoma-like areas: a case report.International journal of clinical and experimental pathology · 2019Article
- Ewing Sarcoma and Primitive Neuroectodermal Tumor of the Thoracic Esophagus: Case Report and Comprehensive Literature Review.Case reports in oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAs of 2013, the WHO has classified peripheral primitive neuroectodermal tumors (PNETs) within the umbrella of Ewing sarcoma family of tumors (ESFTs) given their shared biology. Histologic features differ between PNET and Ewing sarcoma (ES), and potential clinical differences between PNET and ES have not been fully elucidated.
methodsThrough the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database, we identified 3,575 patients identified with histologic diagnosis of ES or PNET from 1973 to 2014. We used Fisher's exact tests to compare patient and tumor characteristics between groups. Kaplan-Meier methods were used to estimate overall survival.
resultsPatients with ES were more likely to be male, ≤18 years old at diagnosis, white, and hispanic compared to patients with PNET (
conclusionsDespite shared underlying biology, patients with PNET and ES show differences in clinical presentation and overall survival, with the latter differences largely mitigated in more recent decades.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.